Crispr Therapeutics AG
CRSP
$49.25-4.41%
End of day · as of Oct 17, 2026, 8:00 AM ET
Mkt cap
$5.42B
EV/Sales
1445.3
P/E ratio
N/A
FY2025 Revenue
$3.51M
EPS (TTM)
$-4.71
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-16569.77%
Beta
1.73
Div yield
N/A
Sector
Healthcare
Crispr Therapeutics AG (CRSP) is a biotechnology company listed on US.
Latest reported CRSP revenue for 2025-12-31 was $3.5M. Net income was -$581.6M. Revenue was down 90.6% from 2024-12-31 to 2025-12-31. CRSP currently screens at market cap $5.42B.
Use this CRSP research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full CRSP income, balance, and cash tables.
Crispr Therapeutics AG (CRSP) is a biotechnology company in the Healthcare sector.
Latest cached Crispr Therapeutics AG (CRSP) revenue for Dec 31, 2025 was $3.5M. Net income was -$581.6M. Statements: https://lician.com/financials/crsp
Crispr Therapeutics AG (CRSP) market capitalization is $5.42B on the latest cached snapshot.
Crispr Therapeutics AG (CRSP) cached previous close $51.52; day range $49.25 – $51.20; volume 1,517,335. Session quote: https://lician.com/quote/crsp
Crispr Therapeutics AG (CRSP) latest cached earnings event is "CRSP earnings" on Aug 3, 2026. Earnings calendar: https://lician.com/earnings
The latest cached CRSP filing is 8-K · Aug 3, 2026. Filings: https://lician.com/sec/crsp